Back
Altimmune Stock Price Chart
Sponsored
ALT
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Buy
58
ALT
Altimmune
Last Price:
7.80
Seasonality Move:
0.83%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Altimmune Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.51 | Buy |
20-day SMA: | 6.96 | Buy |
50-day SMA: | 6.73 | Buy |
200-day SMA: | 8.11 | Sell |
8-day EMA: | 7.45 | Buy |
20-day EMA: | 7.11 | Buy |
50-day EMA: | 6.9 | Buy |
200-day EMA: | 7.1 | Buy |
Altimmune Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.29 | Buy |
Relative Strength Index (14 RSI): | 62.92 | Buy |
Chaikin Money Flow: | 2052895 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.48 - 7.44) | Buy |
Bollinger Bands (100): | (6.25 - 7.57) | Buy |
Altimmune Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Altimmune Stock
Is Altimmune Stock a Buy?
- Altimmune share price is 7.79 while ALT 8-day simple moving average is 7.51, which is a Buy signal.
- The stock price of ALT is 7.79 while Altimmune 20-day SMA is 6.96, which makes it a Buy.
- Altimmune 50-day simple moving average is 6.73 while ALT share price is 7.79, making it a Buy technically.
- ALT stock price is 7.79 and Altimmune 200-day simple moving average is 8.11, creating a Sell signal.
ALT Technical Analysis vs Fundamental Analysis
Altimmune Stock Info
Market Cap:
553.64M
Price in USD:
7.79
Share Volume:
2.97M
Altimmune 52-Week Range
52-Week High:
14.84
52-Week Low:
2.09
Buy
58
Altimmune (ALT)
is a Buy
Altimmune Share Price Forecast
-
What is the Altimmune stock price today?
The Altimmune stock price is 7.79 USD today. -
Will ALT stock go up or go down?
Altimmune> share price is forecast to RISE/FALL based on technical indicators -
Is Altimmune overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Altimmune is not overvalued.
Is Altimmune Stock a Buy?
- Altimmune share price is 7.79 while ALT 8-day exponential moving average is 7.45, which is a Buy signal.
- The stock price of ALT is 7.79 while Altimmune 20-day EMA is 7.11, which makes it a Buy.
- Altimmune 50-day exponential moving average is 6.90 while ALT share price is 7.79, making it a Buy technically.
- ALT stock price is 7.79 and Altimmune 200-day simple moving average is 7.10, creating a Buy signal.
Fundamental Analysis of Altimmune
Is Altimmune a good investment?
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.66 per share, and a decrease next year of $0.29 per share.
Technical Analysis of Altimmune
Should I short Altimmune stock?
- ALT Moving Average Covergence Divergence (MACD) indicator is 0.29, suggesting Altimmune is a Buy
- Altimmune Relative Strength Index (RSI) is 62.92, which suggest Altimmune is overbought
- The Bollinger Bands (25) for Altimmune is (6.48 - 7.44), which suggest Altimmune is a Buy
- The Bollinger Bands (100) for Altimmune is (6.25 - 7.57), which suggest Altimmune is a Buy
* Altimmune stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.